About VMS Asset Management
VMS Group was established in 2006. Since then, it has grown to become a leading multi-strategy financial group providing individual, corporate and institutional investors with specialized investment solutions as well as securities brokerage and corporate finance advisory services.
VMS Asset Management Headquarter Location
49/F One Exchange Square 8 Connaught Place, Central
Latest VMS Asset Management News
May 28, 2019
May 27, 2019 New Horizon Health, a Chinese early-stage cancer screening developer, has secured $66 million in a series C funding round while medical device e-commerce platform LyncMed has raised $20 million in a series B+1 round. SoftBank-backed New Horizon Health raises $66m Series C New Horizon Health, a Chinese early-stage cancer screening developer, has secured $66 million in a Series C funding round led by Hong Kong-based private equity firm VMS Investment Group, China Money Network reported . The company’s existing investors, SoftBank China Venture Capital (SBCVC), and Legend Capital, a venture capital affiliate of Legend Holdings, also participated in the new round. Credit Suisse served as the exclusive financial advisor. Founded in 2015, New Horizon Health develops gastric cancer detection and screening technology products primarily for gastrointestinal cancer. The company offers colorectal cancer products based on fecal gene analysis (FIT-DNA) technology. It allows users to sample at home to discover signs of colon cancer and progress adenomas with a diameter of more than one centimetre. Hong Kong-based VMS Investment Group is a private equity firm. The firm has made six investments to date, according to Crunchbase. In the healthcare sector, Chinese innovative drugs developer Allist Pharmaceuticals recently raised 1.18 billion yuan ($170.75 million) in a new funding round led by healthcare-focused private equity firm Shiyu Capital. China’s LyncMed closes $20m Series B+1 Round Chinese medical device e-commerce platform LyncMed has raised $20 million in a Series B+1 round of financing led by VisionMax Health Fund (VHF), China Money Network reported . Founded in December 2015, LyncMed is a provider of medical and health care products to hospitals and clinics, nursing homes and long-term care facilities, private medical practices, therapists, dental clinics and more. China’s medical devices market is worth 462 billion yuan ($74 billion), and growing at 20 per cent a year, according to Citic Bank.